Breviscapin

CAS No. 116122-36-2

Breviscapin( —— )

Catalog No. M17848 CAS No. 116122-36-2

Breviscapine is the total flavonoid components (the content of scutellarin > or =85%) extracted from the dried whole plant of Erigeron breviscapus.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
50MG 31 In Stock
100MG 47 In Stock
200MG Get Quote In Stock
500MG 107 In Stock
1G 156 In Stock

Biological Information

  • Product Name
    Breviscapin
  • Note
    Research use only, not for human use.
  • Brief Description
    Breviscapine is the total flavonoid components (the content of scutellarin > or =85%) extracted from the dried whole plant of Erigeron breviscapus.
  • Description
    Breviscapine is the total flavonoid components (the content of scutellarin > or =85%) extracted from the dried whole plant of Erigeron breviscapus.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    RAAS
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    116122-36-2
  • Formula Weight
    908.72
  • Molecular Formula
    C21H18O11
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (77.32 mM)
  • SMILES
    c1cc(ccc1c1cc(=O)c2c(c(c(cc2o1)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)C(=O)O)O)O)O)O)O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Xia H, et al. Biol Pharm Bull. 2007 Jul;30(7):1308-16.
molnova catalog
related products
  • Resorcinolnaphthalei...

    Resorcinolnaphthalein is a specific?enhancer of angiotensin-converting enzyme 2 (ACE2) (EC50 value of 19.5 μM). ACE2 activity in a dose-dependent manner enhanced by Resorcinolnaphthalein (100 μM) and XNT (EC50 values of 19.5 μM and 20.1 μM, respectively).

  • A 779 3TFA(159432-28...

    A 779(3TFA) is a potent antagonist of angiotensin-(1-7) receptor?A-779 suppresses the proliferating cell nuclear antigen (PCNA) protein expression up-regulated by Ang II, but A-779 alone has no effect to induce proliferation and migration of VSMCs.?

  • Ripisartan

    Ripisartan (UP-269-6) is a potent and specific angiotensin II receptor antagonist that inhibits angiotensin II-mediated sympathetic tachycardia responses.